Role of microRNAs in peripheral artery disease (Review)

Molecular Medicine Reports

Volumn 6, Issue 4, 2012, Pages 695-700

  Zhou, Xiangyu ^a,b   Yuan, Ping ^a   He, Yanzheng ^a  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Endothelial cell; microRNAs; Peripheral arterial disease; Vascular smooth muscle cell

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 100; MICRORNA 126; MICRORNA 143; MICRORNA 145; MICRORNA 146A; MICRORNA 21; MICRORNA 210; MICRORNA 221; MICRORNA 222; MICRORNA 29B; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; DIABETES MELLITUS; ENDOTHELIUM CELL; HUMAN; MUSCLE FIBER CONTRACTION; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REVIEW; SMOOTH MUSCLE FIBER; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; ATHEROSCLEROSIS; DIABETES COMPLICATIONS; ENDOTHELIAL CELLS; HUMANS; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; PERIPHERAL ARTERIAL DISEASE; RNA, LONG NONCODING;

EID: 84865189222     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.978     Document Type: Review

References (61)

1. Mughal NA, Russell DA, Ponnambalam S and Homer-Vanniasinkam S: Gene therapy in the treatment of peripheral arterial disease. Br J Surg 99: 6-15, 2012.
2. Thijssen DH, Cable NT and Green DJ: Impact of exercise training on arterial wall thickness in humans. Clin Sci (Lond) 122: 311-322, 2012.
3. Fang J, Song XW, Tian J, Chen HY, Li DF, Wang JF, Ren AJ, Yuan WJ and Lin L: Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis 17: 410-423, 2012.
4. Meister G: miRNAs get an early start on translational silencing. Cell 131: 25-28, 2007.
5. Schier AF: The maternal-zygotic transition: death and birth of RNAs. Science 316: 406-407, 2007.
6. Carrington JC and Ambros V: Role of microRNAs in plant and animal development. Science 301: 336-338, 2003. (Pubitemid 36877060)
7. Zampetaki A and Mayr M: MicroRNAs in vascular and metabolic disease. Circ Res 110: 508-522, 2012.
8. Shantikumar S, Caporali A and Emanueli C: Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res 93: 583-593, 2011.
9. Katare R, Riu F, Mitchell K, Gubernator M, Campagnolo P, Cui Y, Fortunato O, Avolio E, Cesselli D, Beltrami AP, Angelini G, Emanueli C and Madeddu P: Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res 109: 894-906, 2011.
10. Wang XQ, Nigro P, World C, Fujiwara K, Yan C and Berk BC: Thioredoxin interacting protein promotes endothelial cell inflammation in response to disturbed flow by increasing leukocyte adhesion and repressing kruppel-like factor 2. Circ Res 110: 560-568, 2012.
11. Zakkar M, Luong le A, Chaudhury H, et al: Dexamethasone arterializes venous endothelial cells by inducing mitogenactivated protein kinase phosphatase-1: a novel antiinflammatory treatment for vein grafts? Circulation 123: 524-532, 2011.
12. Pall T, Pink A, Kasak L, Turkina M, Anderson W, Valkna A and Kogerman P: Soluble CD44 interacts with intermediate filament protein vimentin on endothelial cell surface. PLoS One 6: e29305, 2011.
13. Brouillet S, Hoffmann P, Benharouga M, Salomon A, Schaal JP, Feige JJ and Alfaidy N: Molecular characterization of EG-VEGFmediated angiogenesis: differential effects on microvascular and macrovascular endothelial cells. Mol Biol Cell 21: 2832-2843, 2010.
14. Sabatel C, Malvaux L, Bovy N, Deroanne C, Lambert V, Gonzalez ML, Colige A, Rakic JM, Noel A, Martial JA and Struman I: MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells. PLoS One 6: e16979, 2011.
15. Parikh VN, Jin RC, Rabello S, et al: MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation 125: 1520-32, 2012.
16. Zhou J, Wang KC, Wu W, Subramaniam S, Shyy JY, Chiu JJ, Li JY and Chien S: MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc Natl Acad Sci USA 108: 10355-10360, 2011.
17. Weber M, Baker MB, Moore JP and Searles CD: MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem Biophys Res Commun 393: 643-648, 2010.
18. Harris TA, Yamakuchi M, Ferlito M, Mendell JT and Lowenstein CJ: MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 105: 1516-1521, 2008. (Pubitemid 351346546)
19. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY and Srivastava D: miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15: 272-284, 2008.
20. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R and Olson EN: The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15: 261-271, 2008.
21. Zernecke A, Bidzhekov K, Noels H, et al: Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2: ra81, 2009.
22. Van Solingen C, Seghers L, Bijkerk R, et al: Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J Cell Mol Med 13: 1577-1585, 2009.
23. Zhu N, Zhang D, Chen S, Liu X, Lin L, Huang X, Guo Z, Liu J, Wang Y, Yuan W and Qin Y: Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis 215: 286-293, 2011.
24. Dentelli P, Rosso A, Orso F, Olgasi C, Taverna D and Brizzi MF: microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler Thromb Vasc Biol 30: 1562-1568, 2010.
25. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, Capogrossi MC and Martelli F: MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283: 15878-15883, 2008.
26. Qin B, Xiao B, Liang D, Xia J, Li Y and Yang H: MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and Bcl-2 expression. Biochem Biophys Res Commun 410: 127-133, 2011.
27. Ghosh G, Subramanian IV, Adhikari N, et al: Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis. J Clin Invest 120: 4141-4154, 2010.
28. Ni CW, Qiu H and Jo H: MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. Am J Physiol Heart Circ Physiol 300: 1762-1769, 2011.
29. Qin ZX, Yu P, Qian DH, et al: Hydrogen-rich saline prevents neointima formation after carotid balloon injury by suppressing ROS and the TNF-alpha/NF-kappaB pathway. Atherosclerosis 220: 343-350, 2012.
30. Fogelstrand P, Mellander S and Mattsson E: Increased vascular injury reduces the degree of intimal hyperplasia following angioplasty in rabbits. J Vasc Res 48: 307-315, 2011.
31. Davis BN, Hilyard AC, Nguyen PH, Lagna G and Hata A: Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 284: 3728-3738, 2009.
32. Chen J, Yin H, Jiang Y, Radhakrishnan SK, Huang ZP, Li J, Shi Z, Kilsdonk EP, Gui Y, Wang DZ and Zheng XL: Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arterioscler Thromb Vasc Biol 31: 368-375, 2011.
33. Xie C, Huang H, Sun X, Guo Y, Hamblin M, Ritchie RP, Garcia-Barrio MT, Zhang J and Chen YE: MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4. Stem Cells Dev 20: 205-210, 2011.
34. Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, Dean DB and Zhang C: MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol 170: 1831-1840, 2007. (Pubitemid 47339258)
35. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB and Zhang C: MicroRNA expression signature and antisensemediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 100: 1579-1588, 2007. (Pubitemid 46897261)
36. Lin Y, Liu X, Cheng Y, Yang J, Huo Y and Zhang C: Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. J Biol Chem 284: 7903-7913, 2009.
37. Wang X, Cheng Y, Liu X, Yang J, Munoz D and Zhang C: Unexpected pro-injury effect of propofol on vascular smooth muscle cells with increased oxidative stress. Crit Care Med 39: 738-745, 2011.
38. Boettger T, Beetz N, Kostin S, Schneider J, Kruger M, Hein L and Braun T: Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 119: 2634-2647, 2009.
39. Quintavalle M, Elia L, Condorelli G and Courtneidge SA: MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro. J Cell Biol 189: 13-22, 2010.
40. Xin M, Small EM, Sutherland LB, Qi X, McAnally J, Plato CF, Richardson JA, Bassel-Duby R and Olson EN: MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev 23: 2166-2178, 2009.
41. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN and Srivastava D: miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710, 2009.
42. Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV, Peterson KL, Indolfi C, Catalucci D, Chen J, Courtneidge SA and Condorelli G: The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 16: 1590-1598, 2009.
43. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES and Zhang C: MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 105: 158-166, 2009.
44. Kishore R, Krishnamurthy P and Losordo DW: Career moves: induced pluripotent cells from human aortic smooth muscle cells can efficiently redifferentiate into parental phenotype. Circ Res 106: 7-9, 2010.
45. Liu X, Cheng Y, Zhang S, Lin Y, Yang J and Zhang C: A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104: 476-487, 2009.
46. Liu X, Cheng Y, Yang J, Xu L and Zhang C: Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. J Mol Cell Cardiol 52: 245-255, 2012.
47. Chen KC, Wang YS, Hu CY, Chang WC, Liao YC, Dai CY and Juo SH: OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J 25: 1718-1728, 2011.
48. Sun SG, Zheng B, Han M, Fang XM, Li HX, Miao SB, Su M, Han Y, Shi HJ and Wen JK: miR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep 12: 56-62, 2011.
49. Yu ML, Wang JF, Wang GK, You XH, Zhao XX, Jing Q and Qin YW: Vascular smooth muscle cell proliferation is influenced by let-7d microRNA and its interaction with KRAS. Circ J 75: 703-709, 2011.
50. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, Shah A, Willeit J and Mayr M: Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107: 810-817, 2010.
51. Zhang Y, Wang Y, Wang X, Eisner GM, Asico LD, Jose PA and Zeng C: Insulin promotes vascular smooth muscle cell proliferation via microRNA-208-mediated downregulation of p21. J Hypertens 29: 1560-1568, 2011.
52. Su XL, Wang Y, Zhang W, Zhao LM, Li GR and Deng XL: Insulin-mediated upregulation of K(Ca)3.1 channels promotes cell migration and proliferation in rat vascular smooth muscle. J Mol Cell Cardiol 51: 51-57, 2011.
53. Li Y, Song YH, Li F, Yang T, Lu YW and Geng YJ: MicroRNA-221 regulates high glucose-induced endothelial dysfunction. Biochem Biophys Res Commun 381: 81-83, 2009.
54. Togliatto G, Trombetta A, Dentelli P, Rosso A and Brizzi MF: MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose- and AGE-mediated vascular cell damage. Diabetologia 54: 1930-1940, 2011.
55. Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM and Hu RM: MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol 36: 181-188, 2009.
56. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher AM and Dimmeler S: MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324: 1710-1713, 2009.
57. Grundmann S, H ans F P, K inniry S, H einke J, H elbing T, Bluhm F, Sluijter JP, Hoefer I, Pasterkamp G, Bode C and Moser M: MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells. Circulation 123: 999-1009, 2011.
58. Wang M, L i W, C hang G Q, Ye C S, O u J S, L i X X, L iu Y, Cheang TY, Huang XL and Wang SM: MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities. Arterioscler Thromb Vasc Biol 31: 2044-2053, 2011.
59. Li T, Cao H, Zhuang J, Wan J, Guan M, Yu B, Li X and Zhang W: Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin Chim Acta 412: 66-70, 2011.
60. Fichtlscherer S, Zeiher AM and Dimmeler S: Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol 31: 2383-2390, 2011.
61. Caporali A, Meloni M, Vollenkle C, Bonci D, Sala-Newby GB, Addis R, Spinetti G, Losa S, Masson R, Baker AH, Agami R, le Sage C, Condorelli G, Madeddu P, Martelli F and Emanueli C: Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation 123: 282-291, 2011.